Efficacy of intravenous immunoglobulins in central pontine myelinolysis;Eficacia de las inmunoglobulinas intravenosas en la mielinolisis central pontina

Neurologia

Volumn 23, Issue 6, 2008, Pages 392-394

  Escribano Gascon A B ^a   Casanova Peno L I ^a   Bartolome Puras M ^a   Porta Etessam, Jesús ^a,b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NONE   (Spain)

Author keywords

Central pontine myelinolysis; Intravenous immunoglobulin; Prognosis; Treatment

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN;

ADULT; ALCOHOLISM; ARTICLE; BULIMIA; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; DELIRIUM TREMENS; DYSARTHRIA; FEMALE; GAIT DISORDER; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; IMPULSIVENESS; INTENSIVE CARE UNIT; NUCLEAR MAGNETIC RESONANCE IMAGING; QUADRIPLEGIA;

EID: 48149093652     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Martín R J. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosur Psychiatry 2004;75:(Suppl. 3):22-8.
2. Finsterer J, Engelmayer E, Trnka E, Stiskal M. Immunoglobulins are effective in pontine myelinolysis. Clin Neuropharmacol 2000;23:110-3.
3. Deleu D, Salim K, Mesraoua B, El Siddig A, Al Hail H, Hanssens Y. «Man-in-the-barrel» syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin. J Neurol Sci 2005;237:103-6.
4. Sugimura Y, Murase T, Takefuji S, Hayasaka S, Takagishi Y, Oiso Y, et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 2005;192:178-83.
5. Murase T, Sugimura Y, Takefuji S, Oiso Y, Murata Y. Mechanisms and therapy of osmotic demyelination. Am J Med 2006;119(Suppl. 1):S69-73.
6. González de la Aleja J, Porta-Etessam J, Escribano-Vera J. Déficit neurológico progresivo. En: Porta-Etessam J, Álvarez-Linera J, editores. Neuroimagen: diagnóstico, técnicas, secuencias. Madrid: Luzán 5, 2007; p. 157-78.